The Human Values in AI Healthcare
The Human Values in AI Healthcare
AI Summary
Bulleted
Text
Key Insights
- The document explores ethical considerations in using AI, especially Large Language Models (LLMs), in healthcare decision-making.
- It discusses the need for both normative and personalized models to align AI decisions with overarching policies and individual preferences.
- The document highlights the challenges in understanding medical preferences in LLMs, including consistency and steerability.
- It presents a case study on the concordance of different LLMs in triage decisions, showing variability in their performance and alignment with expert opinions.
- The study introduces the Alignment Compliance Index (ACI) as a metric to evaluate how well LLMs can be aligned with specific preferences.
#AIinHealthcare
#PatientCare
#HumanValues
#PersonalizedMedicine
#MedicalEthics
Explore the critical intersection of AI and human values in medicine. Delve into patient prioritization, decision-making frameworks, and the role of Large Language Models (LLMs) in shaping healthcare.
#AIinHealthcare
#PatientCare
#HumanValues
#PersonalizedMedicine
#MedicalEthics

1/20

2/20

3/20

4/20

5/20

6/20

7/20

8/20

9/20

10/20

11/20

12/20

13/20

14/20

15/20

16/20

17/20

18/20

19/20

20/20
The Human Values in AI Healthcare
- 1. The Human Values Project For The AI We Want Isaac S. Kohane, MD, PhD
- 2. What values do we expect from our doctor?
- 3. Patient management platform, promoting personalized, preventative & proactive medical care CLALIT
- 4.
- 5. Patient prioritized for proactive preventive intervention
- 6. Patient prioritization for proactive care These factors all influence the utility of prioritizing a specific patient, resembling the motivation behind the QALY framework The challenge: How should these factors be combined into a single prioritization schema? We currently identify 3 patient-level components that should potentially take place in the prioritization process: 1. The patient’s risk for the outcome we aim to prevent (can be expressed as an absolute, individualized predicted risk) 2. The patient’s life expectancy (can be evaluated using a relevant prediction model or with age as a proxy) 3. The significance and quantity of care gaps that the proactive intervention can address (can be quantified according to the list of practical care recommendations)
- 7.
- 8. Values and stakeholders
- 9. Big stakes. Present challenge
- 10. Classic Ethical Framing Principles
- 11.
- 12. Why do we need both normative model & personal model • Preferences of individuals may not align with overarching policies. • Preferences across stakeholders (e.g. doctors, patients, public health) may not be resolvable with a consistent set of decisions. • Knowledge of preferences of classes of individuals allows automated personalization. For example: • Parents of children with autism with severe developmental delay. • Individuals undiagnosed and and rapidly weakening. • Young adults concerned about their family history of heart disease. • Elderly patients with painful terminal disease. • Knowledge of preferences of classes of individuals will flag lack of alignment with explicit institutional policy.
- 13. What do we know about medical preferences in LLMs. • Precious little (data for pre-trained model, data for RLHF++, in-context steering). • We do not know: Which models ‘out of the box’ are best aligned • We do not know: How consistent are they in following a particular perspective. • We do not know. How well they can be moved to a specific set of preferences (aka aligned) • We do not know: Can they represent perspectives of all parties. • We do not know: Where in the multiverse of medical decisions their decisions most resemble normative or particular patient context.
- 14. Case Study • Concordance
- 15. Case Study • Consistency • How do you feel if your doctor changes her decisions a lot?
- 16. Case Study • Alignability
- 17. Steerability wrt Decision Vector D
- 18. Alignment Compliance Index
- 19.
- 20.
Related Jaunts

NextGen 2024: Weaning meds when disease is controlled Session Part 2
@SJIA_Foundation
4 months ago •
389 views

Rethinking Interface Design for the Age of Artificial Intelligence
@pacificleo
1 week ago •
67 views

NextGen 2024: Bone Marrow Transplantation (BMT) Session Part 5
@SJIA_Foundation
4 months ago •
264 views

Policy Shifts Against The mRNA Platform Rapidly Emerged This Past Week
@powderhownd1492
4 months ago •
335 views

NextGen 2024: Monitoring &Treating Lung Disease in SJIA Session Part 2
@SJIA_Foundation
4 months ago •
325 views

The Artificial Intelligence Challenge And The End Of The World
@Blockchainboss
4 months ago •
295 views